<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-0011</journal-id>
<journal-title><![CDATA[Revista de la Facultad de Medicina]]></journal-title>
<abbrev-journal-title><![CDATA[rev.fac.med.]]></abbrev-journal-title>
<issn>0120-0011</issn>
<publisher>
<publisher-name><![CDATA[Universidad Nacional de Colombia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-00112020000200245</article-id>
<article-id pub-id-type="doi">10.15446/revfacmed.v68n2.71715</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Distribución geográfica y factores de riesgo de tuberculosis multidrogorresistente en el centro de Perú]]></article-title>
<article-title xml:lang="en"><![CDATA[Geographical distribution and risk factors for multidrug-resistant tuberculosis in central Peru]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Montalvo-Otivo]]></surname>
<given-names><![CDATA[Raúl]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramírez-Breña]]></surname>
<given-names><![CDATA[María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bruno-Huamán]]></surname>
<given-names><![CDATA[Astrid]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Damián-Mucha]]></surname>
<given-names><![CDATA[Milagros]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vilchez-Bravo]]></surname>
<given-names><![CDATA[Stephany]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Quisurco-Cárdenas]]></surname>
<given-names><![CDATA[Merly]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional de Centro de Perú Facultad de Medicina Humana ]]></institution>
<addr-line><![CDATA[Huancayo ]]></addr-line>
<country>Peru</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Regional Docente Clínico Quirúrgico  ]]></institution>
<addr-line><![CDATA[Huancayo ]]></addr-line>
<country>Perú</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Continental Facultad de Ciencias de la Salud ]]></institution>
<addr-line><![CDATA[Huancayo ]]></addr-line>
<country>Perú</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2020</year>
</pub-date>
<volume>68</volume>
<numero>2</numero>
<fpage>245</fpage>
<lpage>250</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-00112020000200245&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-00112020000200245&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-00112020000200245&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción. De acuerdo con la Organización Mundial de la Salud, la tuberculosis multidrogorresistente (TB-MDR), definida como aquella en la que hay resistencia a isoniacida y rifampicina, representa una seria amenaza para la salud pública, ya que en 2018 se reportaron cerca de medio millón de nuevos casos de tuberculosis resistente a la rifampicina, de los cuales el 78% tenían TB-MDR. En Perú, 6 personas se enferman de tuberculosis (TB) cada hora y de los 27 000 casos notificados de enfermedad activa por año, el 10% corresponde a TB-MDR.  Objetivo. Determinar la distribución geográfica de la TB-MDR y los factores de riesgo de esta enfermedad en la región de Junín, ubicada en el centro de Perú.  Materiales y métodos. Estudio longitudinal retrospectivo de casos y controles que incluyó 3 602 personas con diagnóstico de tuberculosis confirmado con cultivo positivo para Mycobacterium tuberculosis entre enero y diciembre de 2016. Los casos fueron los pacientes con diagnóstico de TB-MDR y los controles, los demás pacientes.  Resultados. Se encontró una mayor prevalencia de casos de TB-MDR en la selva central de Perú, zona con alta incidencia de TB. Al realizar el análisis multivariado, se encontraron los siguientes factores de riesgo de multidrogorresistencia: antecedente de tratamiento de la TB (OR: 1.61, IC95%: 1.14-3.26), fracaso del tratamiento previo (OR: 5.84, IC95%: 4.03-8.21) y contacto intradomiciliario con personas con TB-MDR (OR: 91.57, IC95%: 34.56-289.14).  Conclusiones. La distribución geográfica de la TB-MDR es de tipo no heterogéneo con alta incidencia en la selva central. En pacientes con diagnóstico reciente de TB, se debe considerar la posibilidad de TB-MDR si presentan alguno de los factores de riesgo identificados aquí y proceden de alguna zona de alta prevalencia de esta enfermedad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: According to the World Health Organization, multidrugresistant tuberculosis (MDR TB), defined as TB cases in which there is resistance to rifampicin and isoniazid, is a serios threat for public health, since nearly half million new cases of rinfampicin-resistant TB were reported in 2018, of which 78% were MDR TB. In Peru, 6 people fall ill with tuberculosis (TB) every hour and out of the 27 000 active TB cases reported per year, 10% are MDR TB cases.  Objective: To determine the geographical distribution of MDR TB and the risk factors of this disease in the Junín region, located in central Peru.  Materials and methods: Retrospective longitudinal case-control study. The study population consisted of 3 602 people with TB diagnosis confirmed with positive cultures for M. tuberculosis between January and December 2016. Cases were made up of patients diagnosed with MDR TB, and the remaining patients were the controls.  Results: A higher prevalence of MDR-TB cases was observed in the central jungle of Peru, an area with a high incidence of TB. After performing the multivariate analysis, the following risks factors for developing multidrug resistance were found: history of TB treatment (OR: 1.61, 95%CI: 1.14-3.26), prior treatment failure (OR: 5.84, 95%CI: 4.03-8.21) and intra-household contact with people with MDR-TB (OR: 91.57, 95%CI: 34.56-289.14).  Conclusions: The geographical distribution of MDR TB is non-heterogeneous and has a high incidence in the central jungle. In the case of patients recently diagnosed with TB, the possibility of MDR TB diagnosis should be considered if they have at least one of the risk factors identified here and come from an area where this disease is highly prevalent.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Tuberculosis]]></kwd>
<kwd lng="es"><![CDATA[Tuberculosis resistente a múltiples medicamentos]]></kwd>
<kwd lng="es"><![CDATA[Factores de riesgo (DeCS)]]></kwd>
<kwd lng="en"><![CDATA[Tuberculosis]]></kwd>
<kwd lng="en"><![CDATA[Tuberculosis, Multidrug-Resistant]]></kwd>
<kwd lng="en"><![CDATA[Risk Factors (MeSH)]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>World Health Organization (WHO)</collab>
<source><![CDATA[Global tuberculosis report 2019]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Organización Panamericana de la Salud (OPS)</collab>
<source><![CDATA[Tuberculosis en las Américas 2018]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Washington D.C. ]]></publisher-loc>
<publisher-name><![CDATA[OPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Del Castillo]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Ticona]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Saravia]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Somocurcio]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemia de tuberculosis multidrogo rresistente y extensivamente resistente a drogas (TB-MDR/XDR) en el Perú: Situación y propuestas para su control]]></article-title>
<source><![CDATA[Rev Peru Med Exp salud pública]]></source>
<year>2009</year>
<volume>26</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>380-6</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>Perú. Ministerio de Salud Pública de Perú (MINSA)</collab>
<source><![CDATA[Situación de Tuberculosis en el Perú y la respuesta del Estado (Plan de Intervención, Plan de Acción)]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Lima ]]></publisher-loc>
<publisher-name><![CDATA[MINSA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alarcón]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Alarcón]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Figueroa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Ticona]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tuberculosis en el Perú: situación epidemiológica, avances y desafíos para su control]]></article-title>
<source><![CDATA[Rev Perú Med Exp Salud Pública]]></source>
<year>2017</year>
<volume>34</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>299-310</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crispín]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Roque]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Salazar]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Almonacid]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo para tuberculosis multidrogorresistente en establecimientos de salud urbano marginales 2006-2008]]></article-title>
<source><![CDATA[Ciencia e Investigación]]></source>
<year>2012</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>25-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Avalos-Rodríguez]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Imán-Izquierdo]]></surname>
<given-names><![CDATA[FJC]]></given-names>
</name>
<name>
<surname><![CDATA[Virú-Loza]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera-Rivero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zárate-Robles]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Meza-Monterrey]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores asociados a tuberculosis multidrogorresistente primaria en pacientes de Callao]]></article-title>
<source><![CDATA[An Fac Med]]></source>
<year>2014</year>
<volume>75</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>233-6</page-range><publisher-loc><![CDATA[Perú ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>Perú. Ministerio de Salud (MINSA)</collab>
<source><![CDATA[Norma técnica de salud para la atención integral de las personas afectadas por tuberculosis]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Lima ]]></publisher-loc>
<publisher-name><![CDATA[MINSA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<collab>World Health Organization (WHO)</collab>
<article-title xml:lang=""><![CDATA[Treatment of drug-resistant tuberculosis]]></article-title>
<source><![CDATA[Treatment of Tuberculosis: Guidelines]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Washington D.C. ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>Perú. Instituto Nacional de Estadística e Informática</collab>
<source><![CDATA[Perú: Línea de base de los principales indicadores disponible de los objetivos de desarrollo sostenible (ODS)]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Lima ]]></publisher-loc>
<publisher-name><![CDATA[INEI]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="confpro">
<collab>World Medical Association (WMA)</collab>
<source><![CDATA[WMA Declaration of Helsinki - Ethical principles for medical research involving human subjects]]></source>
<year></year>
<conf-name><![CDATA[ 64thGeneral Assembly]]></conf-name>
<conf-loc>Fortaleza </conf-loc>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suárez-García]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Blanco]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vidal-Pérez]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[García-Viejo]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Jaras-Hernández]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain]]></article-title>
<source><![CDATA[Eur J Clin Microbiol Infect Dis]]></source>
<year>2009</year>
<volume>28</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>325-30</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Velásquez]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Yagui]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cegielski]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Asencios]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bayona]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bonilla]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Targeted Drug-Resistance Testing Strategy for Multidrug-Resistant tuberculosis detection, Lima, Peru, 2005-2008]]></article-title>
<source><![CDATA[Emerg Infect Dis]]></source>
<year>2011</year>
<volume>17</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>432-40</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mulu]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Mekonnen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Yimer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Admassu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Abera]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State]]></article-title>
<source><![CDATA[Afr Health Sci]]></source>
<year>2015</year>
<volume>15</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>368-77</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ricks]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Mavhunga]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Modi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Indongo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Zezai]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lambert]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characteristics of multidrug-resistant tuberculosis in Namibia]]></article-title>
<source><![CDATA[BMC Infect Dis]]></source>
<year>2012</year>
<volume>12</volume>
<page-range>2-8</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<collab>Perú. Ministerio de salud (MINSA)</collab>
<source><![CDATA[Análisis de la situación epidemiológica de la tuberculosis en el Perú 2015]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Lima ]]></publisher-loc>
<publisher-name><![CDATA[MINSA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Comstock]]></surname>
<given-names><![CDATA[GW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of tuberculosis]]></article-title>
<source><![CDATA[Am Rev Respir Dis]]></source>
<year>1982</year>
<volume>125</volume>
<page-range>8-15</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres-Chang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Franco-Kuroki]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Franco-Fajardo]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Zapata-Ortega]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo en la aparición de multidrogo pulmonar]]></article-title>
<source><![CDATA[Rev méd panacea]]></source>
<year>2014</year>
<volume>4</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>31-5</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faustini]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hall]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Perucci]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors for multidrug resistant tuberculosis in Europe: a systematic review]]></article-title>
<source><![CDATA[Thorax]]></source>
<year>2006</year>
<volume>61</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>158-63</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Montalvo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bernabe-Ortiz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kirwan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Gilman]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bioimpedance markers and tuberculosis outcome among HIV-infected patients]]></article-title>
<source><![CDATA[Afr J Infect Dis]]></source>
<year>2018</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>47-54</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Iglesias]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chafloque]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Quiñones-Tafur]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilar]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores asociados a multidrogorresistencia en pacientes con tuberculosis en el departamento de Lambayeque]]></article-title>
<source><![CDATA[Rev. cuerpo méd]]></source>
<year>2013</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>16-9</page-range><publisher-name><![CDATA[HNAAA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Basu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Stuckler]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[McKee]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Addressing institutional amplifiers in the dynamics and control of tuberculosis epidemics]]></article-title>
<source><![CDATA[Am J Trop Med Hyg]]></source>
<year>2011</year>
<volume>84</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>30-7</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
